ANGN

Angion Biomedica Corp

1 day chart

About ANGN

Angion Biomedica Corp. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases and acute organ injuries. The Company’s product candidates and programs include ANG-3070, a highly selective oral tyrosine kinase receptor inhibitor (TKI) in development as a treatment for fibrotic diseases, a ROCK2 preclinical program targeted towards the treatment of fibrotic diseases, a CYP11B2 preclinical program targeted towards diseases related to aldosterone synthase dysregulation, and a CYP26 (retinoic acid metabolism) inhibitor program targeted towards a number of biopharmaceutical indications, including cancer, and ANG-3777, a hepatocyte growth factor (HGF) mimetic. Its ROCK2 program includes a number of highly selective, oral small molecule inhibitors of ROCK2 developed internally as a potential treatment for fibrotic and other diseases.

Buy US stocks in Australia starting with ANGN. Open an account and start investing today!

Market Capitalisation

$28.60M

Price-earnings ratio

Dividend yield

0.00%

Volume

406.47K

High today

$1.10

Low today

$0.97

Open price

$1.06

52-week high

$2.04

52-week low

$0.46

ANGN FAQs

Can I buy ANGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy ANGN shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Angion Biomedica Corp?

One share of Angion Biomedica Corp is valued at $1.06.

What is the ticker symbol for Angion Biomedica Corp?

The ticker symbol for Angion Biomedica Corp is ANGN.

How do I buy ANGN shares in Australia?

To buy ANGN stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ANGN

What is the 52-week high for Angion Biomedica Corp stock?

The Angion Biomedica Corp 52-week high stock price is $2.04.

What is the 52-week low for Angion Biomedica Corp stock?

The Angion Biomedica Corp 52-week low stock price is $0.46.

What is the market capitalisation of Angion Biomedica Corp ANGN?

As of 30/05/2023 Angion Biomedica Corp has a market cap of $29M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.